January 4, 2024 — Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a know-how agreement with Mayo Clinic to tackle the prevention and care of heart-related conditions.

January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care solutions, today announced that it has surpassed 250,000 patients receiving a HeartFlow FFRCT Analysis.

A Top 10 look at DAIC's most-read content in December 2023

Here is a rundown of what you and your colleagues found to be most interesting in the field of diagnostic and interventional cardiology during the month of December.

1. Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation
The Diagnostic and Interventional Cardiology (DAIC) team wish you a happy, healthy and prosperous New Year!

The Diagnostic and Interventional Cardiology (DAIC) team wish you a happy, healthy and prosperous New Year!

December 29, 2023 — Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System* as a first-line treatment for persistent

December 27, 2023 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, and

December 27, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now